BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26530085)

  • 1. Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group.
    Dietel M; Bubendorf L; Dingemans AM; Dooms C; Elmberger G; García RC; Kerr KM; Lim E; López-Ríos F; Thunnissen E; Van Schil PE; von Laffert M
    Thorax; 2016 Feb; 71(2):177-84. PubMed ID: 26530085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
    Gridelli C; Ardizzoni A; Douillard JY; Hanna N; Manegold C; Perrone F; Pirker R; Rosell R; Shepherd FA; De Petris L; Di Maio M; de Marinis F
    Lung Cancer; 2010 Jun; 68(3):319-31. PubMed ID: 20036027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas.
    Rossi G; Graziano P; Leone A; Migaldi M; Califano R
    Semin Diagn Pathol; 2013 Nov; 30(4):298-312. PubMed ID: 24342286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer.
    Ellis PM; Blais N; Soulieres D; Ionescu DN; Kashyap M; Liu G; Melosky B; Reiman T; Romeo P; Shepherd FA; Tsao MS; Leighl NB
    J Thorac Oncol; 2011 Aug; 6(8):1379-91. PubMed ID: 21709590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.
    Pirker R; Herth FJ; Kerr KM; Filipits M; Taron M; Gandara D; Hirsch FR; Grunenwald D; Popper H; Smit E; Dietel M; Marchetti A; Manegold C; Schirmacher P; Thomas M; Rosell R; Cappuzzo F; Stahel R;
    J Thorac Oncol; 2010 Oct; 5(10):1706-13. PubMed ID: 20871269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Cost Implications of Universal Versus Locally Advanced-Stage and Advanced-Stage-Only Molecular Testing for Epidermal Growth Factor Receptor Mutations and Anaplastic Lymphoma Kinase Rearrangements in Non-Small Cell Lung Carcinoma: A Tertiary Academic Institution Experience.
    Sauter JL; Butnor KJ
    Arch Pathol Lab Med; 2016 Apr; 140(4):358-61. PubMed ID: 27028394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment.
    Proietti A; Alì G; Pelliccioni S; Lupi C; Sensi E; Boldrini L; Servadio A; Chella A; Ribechini A; Cappuzzo F; Miccoli M; Fontanini G
    Cancer Cytopathol; 2014 Jun; 122(6):445-53. PubMed ID: 24648382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of epidermal growth factor receptor gene T790M mutation in cytology samples using the cobas
    Satouchi M; Tanaka H; Yoshioka H; Shimokawaji T; Mizuno K; Takeda K; Yoshino I; Seto T; Kurata T; Tashiro N; Hagiwara K
    Lung Cancer; 2017 Sep; 111():190-194. PubMed ID: 28838392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular testing in lung cancer: fine-needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication.
    Rafael OC; Aziz M; Raftopoulos H; Vele OE; Xu W; Sugrue C
    Cancer Cytopathol; 2014 Jun; 122(6):454-8. PubMed ID: 24723383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular diagnostics of lung cancer].
    Ryska A; Dziadziuszko R; Olszewski W; Berzinec P; Öz B; Gottfried M; Cufer T; Samarzija M; Plank L; Ostoros G; Tímár J
    Magy Onkol; 2015 Sep; 59(3):259-66. PubMed ID: 26339915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue sampling in lung cancer: a review in light of the MERIT experience.
    Reck M; Hermes A; Tan EH; Felip E; Klughammer B; Baselga J
    Lung Cancer; 2011 Oct; 74(1):1-6. PubMed ID: 21658788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR mutation testing in non-small cell lung cancer (NSCLC).
    Al Dayel F
    J Infect Public Health; 2012 Dec; 5 Suppl 1():S31-4. PubMed ID: 23244184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Rivera MP; Mehta AC; Wahidi MM
    Chest; 2013 May; 143(5 Suppl):e142S-e165S. PubMed ID: 23649436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.
    Kanaji N; Bandoh S; Ishii T; Tadokoro A; Watanabe N; Takahama T; Haba R; Imataki O; Dobashi H; Matsunaga T
    Lung Cancer; 2012 Aug; 77(2):293-8. PubMed ID: 22494566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.
    Brodowicz T; Ciuleanu T; Crawford J; Filipits M; Fischer JR; Georgoulias V; Gridelli C; Hirsch FR; Jassem J; Kosmidis P; Krzakowski M; Manegold C; Pujol JL; Stahel R; Thatcher N; Vansteenkiste J; Minichsdorfer C; Zöchbauer-Müller S; Pirker R; Zielinski CC;
    Ann Oncol; 2012 May; 23(5):1223-1229. PubMed ID: 21940784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Profiling of Advanced Non-Small Cell Lung Cancer in Community Settings: Gaps and Opportunities.
    Gutierrez ME; Choi K; Lanman RB; Licitra EJ; Skrzypczak SM; Pe Benito R; Wu T; Arunajadai S; Kaur S; Harper H; Pecora AL; Schultz EV; Goldberg SL
    Clin Lung Cancer; 2017 Nov; 18(6):651-659. PubMed ID: 28479369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological Society.
    Rajadurai P; Cheah PL; How SH; Liam CK; Annuar MAA; Omar N; Othman N; Marzuki NM; Pang YK; Bustamam RSA; Tho LM
    Lung Cancer; 2019 Oct; 136():65-73. PubMed ID: 31446227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
    Felip E; Concha Á; de Castro J; Gómez-Román J; Garrido P; Ramírez J; Isla D; Sanz J; Paz-Ares L; López-Ríos F
    Clin Transl Oncol; 2015 Feb; 17(2):103-12. PubMed ID: 25351175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer.
    Bozzetti C; Naldi N; Nizzoli R; Azzoni C; Bortesi B; Zobbi V; Bottarelli L; Tiseo M; Gasparro D; Majori M; De Filippo M; Ardizzoni A
    Lung Cancer; 2013 Apr; 80(1):35-8. PubMed ID: 23352033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.